196 related articles for article (PubMed ID: 33179735)
1. Cutaneous Vasculitis After Ustekinumab Induction in Crohn's Disease.
Chugh R; Proctor DD; Little A; Myung P; Cowper S; Imaeda S; Pashankar DS; Al-Bawardy B
Inflamm Bowel Dis; 2021 Feb; 27(3):e30-e31. PubMed ID: 33179735
[No Abstract] [Full Text] [Related]
2. Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
Costa-Moreira P; Lopes S; Santos AL; Pedrosa AF; Andrade P; Portugal R; Macedo G
J Crohns Colitis; 2020 Feb; 14(2):274-276. PubMed ID: 31267125
[TBL] [Abstract][Full Text] [Related]
3. Ustekinumab-induced leukocytoclastic vasculitis in a young male with Crohn's disease.
Zhang XP; Wang H; Zhu LR
Dig Liver Dis; 2024 Jun; 56(6):1105-1106. PubMed ID: 38521672
[No Abstract] [Full Text] [Related]
4. Leukocytoclastic vasculitis as a rare dermatologic manifestation of Crohn's disease mimicking cellulitis: a case report.
Buck M; Dumic I; McDermott W; Nordstrom C; Dawan S; Virata A; Martin S; Hudson A; Milovanovic T; Nordin T
BMC Gastroenterol; 2020 Jul; 20(1):240. PubMed ID: 32727390
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with Adalimumab.
Cury DB; de Souza AW; Vianna GA; Odashiro D; Farias A; Moss AC
Inflamm Bowel Dis; 2017 Jan; 23(1):E1-E2. PubMed ID: 27893546
[No Abstract] [Full Text] [Related]
6. Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient.
Cançado GGL; Nardelli MJ; Gouthier MAD
Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):453. PubMed ID: 33512843
[No Abstract] [Full Text] [Related]
7. Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease.
Kishimoto K; Kawashima K; Fukunaga M; Kotani S; Sonoyama H; Oka A; Mishima Y; Oshima N; Ishimura N; Ishikawa N; Maruyama R; Ishihara S
Intern Med; 2021 Feb; 60(3):385-389. PubMed ID: 32863363
[TBL] [Abstract][Full Text] [Related]
8. Leukocytoclastic vasculitis complicating adalimumab therapy for Crohn's disease: Report of three cases.
Bernardes C; Carvalho D; Saiote J; Ramos J
Gastroenterol Hepatol; 2018; 41(7):442-443. PubMed ID: 29054318
[No Abstract] [Full Text] [Related]
9. An Unusual Cause of Skin Rash in Crohn's Disease.
Chebli JMF; de Oliveira Moreira B; da Rocha Ribeiro TC
Gastroenterology; 2018 Sep; 155(3):618-620. PubMed ID: 29409941
[No Abstract] [Full Text] [Related]
10. [Adalimumab vasculitis in a patient with Crohn's disease].
Muñoz Villafranca C; Izu Belloso RM; Bravo Rodriguez MT; Basterra Olabarrieta S
Gastroenterol Hepatol; 2013 Apr; 36(4):296-7. PubMed ID: 23522950
[No Abstract] [Full Text] [Related]
11. Crohn's disease and acute leukocytoclastic vasculitis of skin.
Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI
Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab.
McIlwain L; Carter JD; Bin-Sagheer S; Vasey FB; Nord J
J Clin Gastroenterol; 2003; 36(5):411-3. PubMed ID: 12702983
[TBL] [Abstract][Full Text] [Related]
13. [Leukocytoclastic vasculitis associated with Crohn's disease].
Plaza Santos R; Jaquotot Herranz M; Froilán Torres C; Poza Cordón J; Casado Verrier B; de Tena Díaz-Agero FL; Vázquez López P; Suárez de Parga JM
Gastroenterol Hepatol; 2010; 33(6):433-5. PubMed ID: 19818534
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature.
Smeets FGM; Liedorp PR; van der Poel M; Miclea RL; Masclee AAM; Pierik M
J Crohns Colitis; 2019 Oct; 13(11):1470-1473. PubMed ID: 31116402
[TBL] [Abstract][Full Text] [Related]
15. Leukocytoclastic vasculitis: A rare adverse effect secondary to infliximab.
Karoui S; Bibani N; Ben Gorbel I; Serghini M; Mlika M; Braham A; Chelly I; Haouet S; Houmène H; Filali A
Inflamm Bowel Dis; 2011 Feb; 17(2):E4-5. PubMed ID: 20848511
[No Abstract] [Full Text] [Related]
16. Simultaneous development of sarcoidosis and cutaneous vasculitis in a patient with refractory Crohn's disease during infliximab therapy.
Numakura T; Tamada T; Nara M; Muramatsu S; Murakami K; Kikuchi T; Kobayashi M; Muroi M; Okazaki T; Takagi S; Eishi Y; Ichinose M
BMC Pulm Med; 2016 Feb; 16():30. PubMed ID: 26864464
[TBL] [Abstract][Full Text] [Related]
17. Leukocytoclastic Vasculitis as the Presenting Symptom of Crohn's Disease in an Adolescent.
Ford V; Mooney C; Shah M; Jenkins E
J Investig Med High Impact Case Rep; 2020; 8():2324709620947608. PubMed ID: 32762386
[TBL] [Abstract][Full Text] [Related]
18. Ustekinumab-Induced Remission of Two Cases of Refractory Cutaneous Crohn's Disease.
Patel BM; Ramos Rivers C; Koutroumpakis F; Ahsan M; Dueker J; Hashash J; Johnston E; Barrie A; Harrison J; Schwartz M; Babichenko D; Tang G; Binion D
Inflamm Bowel Dis; 2021 Oct; 27(10):e124. PubMed ID: 33999193
[No Abstract] [Full Text] [Related]
19. Morphea in a Crohn's disease patient undergoing ustekinumab treatment.
Makihara-Inukai M; Takeichi T; Ogawa-Momohara M; Muro Y; Akiyama M
Eur J Dermatol; 2021 Feb; 31(1):96-97. PubMed ID: 33495147
[No Abstract] [Full Text] [Related]
20. Cutaneous polyarteritis nodosa associated with Crohn's disease. Report and review of the literature.
Gudbjörnsson B; Hällgren R
J Rheumatol; 1990 Mar; 17(3):386-90. PubMed ID: 1970606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
